These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 25621554
1. Different concentrations of glucose regulate proliferation and osteogenic differentiation of osteoblasts via the PI3 kinase/Akt pathway. Liu Z, Jiang H, Dong K, Liu S, Zhou W, Zhang J, Meng L, Rausch-Fan X, Xu X. Implant Dent; 2015 Feb; 24(1):83-91. PubMed ID: 25621554 [Abstract] [Full Text] [Related]
2. Alpha-Lipoic Acid Alleviates High-Glucose Suppressed Osteogenic Differentiation of MC3T3-E1 Cells via Antioxidant Effect and PI3K/Akt Signaling Pathway. Dong K, Hao P, Xu S, Liu S, Zhou W, Yue X, Rausch-Fan X, Liu Z. Cell Physiol Biochem; 2017 Feb; 42(5):1897-1906. PubMed ID: 28772267 [Abstract] [Full Text] [Related]
3. Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose microenvironment. Ma P, Gu B, Xiong W, Tan B, Geng W, Li J, Liu H. PLoS One; 2014 Feb; 9(11):e112243. PubMed ID: 25391146 [Abstract] [Full Text] [Related]
4. Concentrate Growth Factors Regulate Osteogenic Dysfunction of MC3T3-E1 Cells Induced by High Glucose Through PI3K/Akt Signaling Pathway. Dong K, Hao P, Zhou W, Liu Z. Implant Dent; 2019 Oct; 28(5):478-483. PubMed ID: 31241545 [Abstract] [Full Text] [Related]
5. The roles of PI3K/Akt signaling pathway in regulating MC3T3-E1 preosteoblast proliferation and differentiation on SLA and SLActive titanium surfaces. Gu YX, Du J, Si MS, Mo JJ, Qiao SC, Lai HC. J Biomed Mater Res A; 2013 Mar; 101(3):748-54. PubMed ID: 22941963 [Abstract] [Full Text] [Related]
7. AEBP1 restores osteoblastic differentiation under dexamethasone treatment by activating PI3K/AKT signalling. Jin R, Li C, Yang Y, Xie J. Clin Exp Pharmacol Physiol; 2024 Nov; 51(11):e13923. PubMed ID: 39358837 [Abstract] [Full Text] [Related]
14. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang H, Peng H. Biomed Pharmacother; 2019 Feb 07; 110():602-608. PubMed ID: 30537677 [Abstract] [Full Text] [Related]
15. Extrapancreatic roles of glimepiride on osteoblasts from rat manibular bone in vitro: Regulation of cytodifferentiation through PI3-kinases/Akt signalling pathway. Ma P, Xiong W, Liu H, Ma J, Gu B, Wu X. Arch Oral Biol; 2011 Apr 07; 56(4):307-16. PubMed ID: 21055727 [Abstract] [Full Text] [Related]
16. The roles of extracellular signal-regulated kinase 1/2 pathway in regulating osteogenic differentiation of murine preosteoblasts MC3T3-E1 cells on roughened titanium surfaces. Zhuang LF, Jiang HH, Qiao SC, Appert C, Si MS, Gu YX, Lai HC. J Biomed Mater Res A; 2012 Jan 07; 100(1):125-33. PubMed ID: 21997903 [Abstract] [Full Text] [Related]
17. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin. Wu X, Li S, Xue P, Li Y. Exp Cell Res; 2017 Nov 15; 360(2):281-291. PubMed ID: 28919123 [Abstract] [Full Text] [Related]